Metropolitan Life Insurance Company (MetLife)’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,735
| Closed | -$58.3K | – | 972 |
|
|
2024
Q1 | $58.3K | Sell |
1,735
-295
| -15% | -$9.91K | ﹤0.01% | 1327 |
|
|
2023
Q4 | $65.6K | Hold |
2,030
| – | – | ﹤0.01% | 1304 |
|
|
2023
Q3 | $66.5K | Buy |
2,030
+212
| +12% | +$6.95K | ﹤0.01% | 1240 |
|
|
2023
Q2 | $64K | Buy |
1,818
+317
| +21% | +$11.2K | ﹤0.01% | 1280 |
|
|
2023
Q1 | $49K | Sell |
1,501
-120
| -7% | -$3.92K | ﹤0.01% | 1406 |
|
|
2022
Q4 | $89.3K | Hold |
1,621
| – | – | ﹤0.01% | 1116 |
|
|
2022
Q3 | $71.8K | Hold |
1,621
| – | – | ﹤0.01% | 1217 |
|
|
2022
Q2 | $79.1K | Buy |
1,621
+205
| +14% | +$10K | ﹤0.01% | 1206 |
|
|
2022
Q1 | $68.9K | Sell |
1,416
-4,631
| -77% | -$225K | ﹤0.01% | 1413 |
|
|
2021
Q4 | $258K | Sell |
6,047
-1,102
| -15% | -$47K | ﹤0.01% | 1841 |
|
|
2021
Q3 | $274K | Hold |
7,149
| – | – | ﹤0.01% | 1844 |
|
|
2021
Q2 | $202K | Buy |
+7,149
| New | +$202K | ﹤0.01% | 2132 |
|